Showing results (701-710 of 1,677) with videos related to

Sort By:
Pageof 168
European Urology Focus|June 22, 2025
Decision Regret About Testicular Prosthesis After Radical Orchiectomy: Real-life Data to Improve Preoperative Patient CounselingLuca Boeri, Federica Passarelli, Massimiliano Raffo, et al.
Fertility and Sterility|April 2, 2019
Impaired testicular signaling of vitamin A and vitamin K contributes to the aberrant composition of the extracellular matrix in idiopathic germ cell aplasiaMassimo Alfano, Filippo Pederzoli, Irene Locatelli, et al.
European Urology|August 9, 2011
The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic schemeVincenzo Scattoni, Marco Raber, Umberto Capitanio, et al.
European Urology Oncology|May 18, 2019
Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic OutcomesAlessandro Larcher, Umberto Capitanio, Geert De Naeyer, et al.
European Urology|September 2, 2009
Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsyVincenzo Scattoni, Marco Raber, Firas Abdollah, et al.
The Journal of Sexual Medicine|October 3, 2009
Postoperative orgasmic function increases over time in patients undergoing nerve-sparing radical prostatectomyAndrew Salonia, Andrea Gallina, Alberto Briganti, et al.
Scientific Reports|February 19, 2021
Patients presenting with lower urinary tract symptoms who most deserve to be investigated for primary bladder neck obstructionNicolò Schifano, Paolo Capogrosso, Rayan Matloob, et al.
European Urology|November 26, 2009
A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomyJochen Walz, Arthur L Burnett, Anthony J Costello, et al.
Current Problems in Cancer|June 9, 2022
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidenceUmberto Capitanio, Giuseppe Fallara, Daniele Raggi, et al.
Critical Reviews in Oncology/Hematology|January 14, 2014
A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinomaSalima Ismail, Malek Meskawi, Jens Hansen, et al.
Pageof 168